Clinical trial

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

NCT02032836

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-03-10

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2014-03-10Date precision: day

Registry last updated2018-09-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Arterial Hypertensionunresolved

Interventions

lloprost(Ventavis,BAYQ6252, 20 µg/mL)DRUG

lloprost(Ventavis,BAYQ6252, 10 µg/mL)DRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

HamburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02032836 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.